Heterologous vs Homologous COVID-19 Booster Vaccination
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study
Lancet 2022 Jan 21;[EPub Ahead of Print], SA Costa Clemens, L Weckx, R Clemens, AV Almeida Mendes, A Ramos Souza, MBV Silveira, SNF da Guarda, MM de Nobrega, MI de Moraes Pinto, IGS Gonzalez, N Salvador, MM Franco, RN de Avila Mendonça, IS Queiroz Oliveira, BS de Freitas Souza, M Fraga, P Aley, S Bibi, L Cantrell, W Dejnirattisai, X Liu, J Mongkolsapaya, P Supasa, GR Screaton, T Lambe, M Voysey, AJ Pollard,From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.